Compared to patients without hs-cTnT elevation and upon adjustment for age, sex, cardiovascular risk factors, and a history of stroke, congestive heart failure, and chronic kidney disease, all patients with either type of MI or myocardial injury had a significantly higher risk for all-cause mortality during follow-up (Fig. 3A). This evidence concerns the gene TNNT2 and Stroke.